1,2-di-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine

Term ID

CHEBI:84538

Synonyms

(2R)-3-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]propyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
GPEtn(22:6/22:6)
GPEtn(22:6n3/22:6n3)
GPEtn(22:6w3/22:6w3)
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(22:6/22:6)
PE(22:6n3/22:6n3)
PE(22:6w3/22:6w3)
Phophatidylethanolamine(22:6/22:6)
Phophatidylethanolamine(22:6n3/22:6n3)
Phophatidylethanolamine(22:6w3/22:6w3)

Definition

A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which both the acyl groups specified is (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1,2-diacyl-sn-glycero-3-phosphoethanolamine

1,2-diacyl-sn-glycero-3-phosphoethanolamine Show first 5 Terms
has_functional_parent: all-cis-docosa-4,7,10,13,16,19-hexaenoic acid

all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Show first 5 Terms
has_role: mouse metabolite

mouse metabolite Show first 5 Terms

Phenotype

Phenotype resulting from 1,2-di-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine

Phenotype where environments contain 1,2-di-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine

Phenotype modified by environments containing 1,2-di-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine

Human Disease Model